Public filings / AVLN on Yahoo Finance (opens in a new tab)
AVLN: insider buying, 13F holders, analyst moves
Avalyn Pharma Inc.
A summary of public filings about Avalyn Pharma Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
4 of our 100 managers hold AVLN
Combined reported value $124.0M.
Holders among our 100 managers: 0 in Q3 2023, 4 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Perceptive Advisors | $88.1M | 1.37% | New |
| Deerfield Company | $24.1M | 0.25% | New |
| Baker Bros. Advisors | $11.5M | 0.06% | New |
| Soros Fund Management | $329K | 0.00% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.